Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.

Schistosomiasis affects over 200 million people and there are concerns whether the current chemotherapeutic control strategy (periodic mass drug administration with praziquantel (PZQ)-the only licenced anti-schistosome compound) is sustainable, necessitating the development of new drugs.We investiga...

Полное описание

Библиографические подробности

Главные авторы:	Madhu K Sundaraneedi, Bemnet A Tedla, Ramon M Eichenberger, Luke Becker, Darren Pickering, Michael J Smout, Siji Rajan, Phurpa Wangchuk, F Richard Keene, Alex Loukas, J Grant Collins, Mark S Pearson
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Public Library of Science (PLoS) 2017-12-01
Серии:	PLoS Neglected Tropical Diseases
Online-ссылка:	http://europepmc.org/articles/PMC5746282?pdf=render
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!